Prognostic value of cytokines in breast cancer: Correlation with positive hormonal status and obesity

[1] Siegel R L, Miller K D. and Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 2016; 66: 7–30. doi:10.3322/caac.21332. SiegelR L MillerK D JemalA Cancer statistics, 2016 CA: A Cancer Journal for Clinicians 2016 66 7 30 10.3322/caac.21332 26742998 Open DOISearch in Google Scholar

[2] Morigi C. Highlights from the 15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer. ecancermedicalscience.2017;11:732. doi:10.3332/ecancer.2017.732. MorigiC Highlights from the 15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer ecancermedicalscience 2017 11 732 10.3332/ecancer.2017.732 540622228491135 Open DOISearch in Google Scholar

[3] Divella R, De Luca R, Abbate I, Naglieri E, Daniele A. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 2016; 7(15):2346–2359. DivellaR De LucaR AbbateI NaglieriE DanieleA Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation J Cancer 2016 7 15 2346 2359 10.7150/jca.16884516654727994674 Search in Google Scholar

[4] Ravishankaran, P., & Karunanithi, R. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World Journal of Surgical Oncology, 2011; 9, 18. http://doi.org/10.1186/1477-7819-9-18. RavishankaranP. KarunanithiR Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patient World Journal of Surgical Oncology 2011 9 18 http://doi.org/10.1186/1477-7819-9-18 10.1186/1477-7819-9-18304597321294915 Search in Google Scholar

[5] Wang, H., & Yang, X. Association between serum cytokines and progression of breast cancer in Chinese population. Medicine, 2017;96(49), e8840. http://doi.org/10.1097/MD.0000000000008840 WangH. YangX. Association between serum cytokines and progression of breast cancer in Chinese population Medicine 2017 96 49 e8840 http://doi.org/10.1097/MD.0000000000008840 10.1097/MD.0000000000008840572886329245248 Search in Google Scholar

[6] Ibrahim S, El-Ghonaimy E, Hassan H, Mahana N, Mahmoud M, TahaniEl-Mamlouk T, El-Shinawi M., Mohamed M. Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression. Journal of Advanced Research, 2016; Volume 7, Issue 5, September, Pages 661–670. IbrahimS El-GhonaimyE HassanH MahanaN MahmoudM TahaniEl-MamloukT El-ShinawiM .MohamedM Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression Journal of Advanced Research 2016 7 5 September 661 670 10.1016/j.jare.2016.06.007495700827482469 Search in Google Scholar

[7] Abana CO, Bingham BS, Cho JH, et al. IL-6 variant is associated with metastasis in breast cancer patients. Coleman WB, ed. PLoS ONE. 2017;12(7):e0181725. doi:10.1371/journal.pone.0181725. AbanaCO BinghamBS ChoJH IL-6 variant is associated with metastasis in breast cancer patients ColemanWB ed. PLoS ONE 2017 12 7 e0181725 10.1371/journal.pone.0181725 552183828732081 Open DOISearch in Google Scholar

[8] Hartman ZC1, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck SG, Mills GB, Brown PH. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 2013; Jun 1;73(11):3470–80. doi: 10.1158/0008-5472.CAN-12-4524-T. Epub 2013 Apr 30. HartmanZC1 PoageGM den HollanderP TsimelzonA HillJ PanupinthuN ZhangY MazumdarA HilsenbeckSG MillsGB BrownPH Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8 Cancer Res 2013 Jun 1 73 11 3470 80 10.1158/0008-5472.CAN-12-4524-T Epub 2013 Apr 30 385311123633491 Open DOISearch in Google Scholar

[9] Xin Zhu, Lingbin Du, Jianguo Feng, et al. Clinicopathological and Prognostic Significance of Serum Cytokine Levels in Breast Cancer. Clinical laboratory, 2013; 60(7):1145–51. XinZhu LingbinDu JianguoFeng Clinicopathological and Prognostic Significance of Serum Cytokine Levels in Breast Cancer Clinical laboratory 2013 60 7 1145 51 10.7754/Clin.Lab.2013.130738 Search in Google Scholar

[10] Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity. Clin Cancer Res, 2016; 22(10); 2329–34. MandaiM HamanishiJ AbikoK MatsumuraN BabaT KonishiI Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity Clin Cancer Res 2016 22 10 2329 34 10.1158/1078-0432.CCR-16-022427016309 Search in Google Scholar

[11] Mostafa AA, Codner D, Hirasawa K, et al. Activation of ERα Signaling Differentially Modulates IFN-γ Induced HLA-Class II Expression in Breast Cancer Cells. Kovats S, ed. PLoS ONE. 2014;9(1):e87377. doi:10.1371/journal.pone.0087377. MostafaAA CodnerD HirasawaK Activation of ERα Signaling Differentially Modulates IFN-γ Induced HLA-Class II Expression in Breast Cancer Cells KovatsS ed. PLoS ONE 2014 9 1 e87377 10.1371/journal.pone.0087377 390365224475282 Open DOISearch in Google Scholar

[12] Marie-Emmanuelle Legrier, et al 2016. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer. British Journal of cancer Cancer volume114, pages 177–187. Marie-EmmanuelleLegrier 2016 Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer British Journal of cancer Cancer 114 177 187 10.1038/bjc.2015.398481580326695443 Search in Google Scholar

[13] NCD Risk Factor Collaboration (NCD-RisC), Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019 May;569(7755):260–264. doi: 10.1038/s41586-019-1171-x. Epub 2019 May 8. NCD Risk Factor Collaboration (NCD-RisC) Rising rural body-mass index is the main driver of the global obesity epidemic in adults Nature 2019 May 569 7755 260 264 10.1038/s41586-019-1171-x Epub 2019 May 8 678486831068725 Open DOISearch in Google Scholar

[14] Gyamfi J, Eom M, Koo JS, Choi J. Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction. Transl Oncol.; 11(2):275–285. doi:10.1016/j.tranon.2017.12.009 GyamfiJ EomM KooJS ChoiJ Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction Transl Oncol. 11 2 275 285 10.1016/j.tranon.2017.12.009588417729413760 Open DOISearch in Google Scholar

[15] Bowers LW, Brenner AJ, Hursting SD, Tekmal RR, deGraffenried LA. Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production. Breast Cancer Res Treat. 2015;149(1):49–57. doi:10.1007/s10549-014-3223-0 BowersLW BrennerAJ HurstingSD TekmalRR deGraffenriedLA Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production Breast Cancer Res Treat 2015 149 1 49 57 10.1007/s10549-014-3223-0 440914025476497 Open DOISearch in Google Scholar

[16] Bougaret L, Delort L, Billard H, et al. Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen. PLoS One;2018; 13 (2): e0191571. doi:10.1371/journal.pone.0191571. BougaretL DelortL BillardH Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen PLoS One 2018 13 2 e0191571 10.1371/journal.pone.0191571 579408629389973 Open DOISearch in Google Scholar

[17] Modified from Schnitt SJ. Will molecular classification replace traditional breast pathology? Int J Surg Pathol. 2010;18:162S–166S. http://dx.doi.org/10.1177/1066896910370771. Modified from SchnittSJ Will molecular classification replace traditional breast pathology? Int J Surg Pathol 2010 18 162S 166S http://dx.doi.org/10.1177/1066896910370771. 10.1177/106689691037077120484283 Search in Google Scholar

[18] Correa Geyer F, Reis-Filho JS. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Int J Surg Pathol. 2009;17:285–302. http://dx.doi.org/10.1177/1066896908328577. Correa GeyerF Reis-FilhoJS Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Int J Surg Pathol 2009 17 285 302 http://dx.doi.org/10.1177/1066896908328577. 10.1177/106689690832857719103611 Search in Google Scholar

[19] El Saeed GK, Hosny Abou-elela DM, Ahmed El-Gendy MT. Evaluation of interleukin-6 and C-reactive protein in patients with breast cancer at Menoufia University Hospitals. Menoufia Med J 2016;29:337–40 El SaeedGK Hosny Abou-elelaDM Ahmed El-GendyMT Evaluation of interleukin-6 and C-reactive protein in patients with breast cancer at Menoufia University Hospitals Menoufia Med J 2016 29 337 40 10.4103/1110-2098.192447 Search in Google Scholar

[20] Noman AS, Uddin M, Chowdhury AA, Nayeem MJ, Raihan Z et al., Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer. Sci Rep. 2017 May 11;7(1):1796. doi: 10.1038/s41598-017-01268-4. NomanAS UddinM ChowdhuryAA NayeemMJ RaihanZ Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer Sci Rep 2017 May 11 7 1 1796 10.1038/s41598-017-01268-4 543175628496132 Open DOISearch in Google Scholar

[21] Huang WC, Hung CM, Wei CT, et al. Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells. Oncotarget, 2016; 7 (38): 62352–62363. doi: 10.18632/oncotarget 11471. HuangWC HungCM WeiCT Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells Oncotarget 2016 7 38 62352 62363 10.18632/oncotarget 11471 Open DOISearch in Google Scholar

[22] Vaysse C, Lømo J, Garred O, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, et al. Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer. npj Breast Cancer, 2017; 3, Article number: 19 (2017). VaysseC LømoJ GarredO FjeldheimF LofteroedT SchlichtingE McTiernanA Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer npj Breast Cancer 2017 3 Article number: 19 (2017) 10.1038/s41523-017-0015-9546013428649659 Search in Google Scholar

[23] Faria SS, Corrêa LH, Heyn GS, de Sant’Ana LP, Almeida RDN, Magalhães KG. Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy. J Breast Cancer, 2020; May; 23(3):233–245. doi: 10.4048/jbc.2020.23.e35. PMID: 32595986; PMCID: PMC7311368. FariaSS CorrêaLH HeynGS de Sant’AnaLP AlmeidaRDN MagalhãesKG Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy J Breast Cancer 2020 May 23 3 233 245 10.4048/jbc.2020.23.e35 PMID: 32595986; PMCID: PMC7311368 731136832595986 Open DOISearch in Google Scholar

[24] Ni L, Lu J. Interferon gamma in cancer immunotherapy. Cancer Med.2018; 7(9):4509–4516. doi: 10.1002/cam4.1700. Epub 2018 Jul 23. PubMed PMID: 30039553; PubMed Central PMCID: PMC6143921. NiL LuJ Interferon gamma in cancer immunotherapy Cancer Med 2018 7 9 4509 4516 10.1002/cam4.1700 Epub 2018 Jul 23. PubMed PMID: 30039553; PubMed Central PMCID: PMC6143921 614392130039553 Open DOISearch in Google Scholar

[25] Mojic M, Takeda K, Hayakawa Y. The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion. Int J Mol Sci. 2017;19(1):89. Published 2017 Dec 28. doi:10.3390/ijms19010089. MojicM TakedaK HayakawaY The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion Int J Mol Sci 2017 19 1 89 Published 2017 Dec 28. 10.3390/ijms19010089 579603929283429 Open DOISearch in Google Scholar

[26] Nagai Y, Tsuchiya H, Ji MQ, Zhang H, Greene MI. Synergistic effect of IFN-γ on breast cancer targeted therapy. The Journal of Immunology, 2017; May, 198 (1 Supplement) 141.14 NagaiY TsuchiyaH JiMQ ZhangH GreeneMI Synergistic effect of IFN-γ on breast cancer targeted therapy The Journal of Immunology 2017 May 198 1 Supplement 141 14 10.4049/jimmunol.198.Supp.141.14 Search in Google Scholar

[27] Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015; 10(3):e0121971. Published 2015 Mar 17. doi:10.1371/journal.pone.0121971 SchmidtFM WeschenfelderJ SanderC Inflammatory cytokines in general and central obesity and modulating effects of physical activity PLoS One 2015 10 3 e0121971 Published 2015 Mar 17. 10.1371/journal.pone.0121971 436336625781614 Open DOISearch in Google Scholar

[28] Mehta SY, Morten BC, Antony J, et al. Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes. Oncotarget. 2018; 9(49):29146–29161. doi:10.18632/oncotarget.25635 MehtaSY MortenBC AntonyJ Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes Oncotarget 2018 9 49 29146 29161 10.18632/oncotarget.25635 604438530018742 Open DOISearch in Google Scholar